AM Header
Doc Placeholder

Clinical Press Releases

Competitive Soccer Linked to Increased Injuries and Menstrual Dysfunction in Girls

Halting Bone-Building Osteoporosis Drug Use Cuts Risk for Additional Atypical Femur Fracture in Half

4.5 Million Americans Living with Total Knee Replacement

Knee Replacement May Lower a Patient’s Risk for Mortality and Heart Failure

Annual Cost of Defensive Orthopaedic Medicine Estimated at $2 Billion

AAOS Focuses on Disaster Responders, both Yesterday’s and Tomorrow’s

Platelet-Rich Plasma (PRP) Therapy: When is PRP Pertinent?

Vitamin D Deficiency High Among Trauma Patients



Embargo for Release
:
           February 7, 2012 - 12:01 a.m. PST

For more information, contact:

Lauren Pearson Riley (847) 384-4031 (708) 227-1773 pearson@aaos.org
Kristina Goel (847) 384-4034 (312) 388-5241 goel@aaos.org

 

Knee Replacement May Lower a Patient’s Risk for Mortality and Heart Failure

SAN FRANCISCO – New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) highlights the benefits of total knee replacement (TKR) in elderly patients with osteoarthritis, including a lower probability of heart failure and mortality.

Investigators reviewed Medicare records to identify osteoarthritis patients, separating them into two groups – those who underwent TKR to relieve symptoms, and those who did not. Outcomes of interest included average annual Medicare payments for related care, mortality, and new diagnoses of congestive heart failure, diabetes and depression. Differences in costs and risk ratios were adjusted for multiple variables including age, sex, race and region. The results (adjusted for underlying health conditions) were compared at fixed periods of one year, three years, five years and seven years after surgery.

The seven-year cumulative average Medicare payments for all treatments were $63,940 for the non-TKR group, and $83,783 for the TKR group, for an incremental increased seven-year cost of $19,843. The cost does not include prescription drugs, which are reportedly much higher in the non-TKR group.

There were significant positives in the osteoarthritis TKR group: the risk of mortality was half that of the non-TKR group and the congestive heart failure rate also was lower, at three, five and seven years after surgery. There was no difference in diabetes rates among both groups. Depression rates were slightly higher in the TKR group during the first three years after surgery, though there was no difference at five and seven years.

“These patients had improved survivorship and reduced risk for cardiovascular conditions,” said Scott Lovald, PhD, MBA, lead investigator and senior associate at Exponent, Inc. “More specifically, total knee replacement in osteoarthritis patients may reduce patient mortality by half. There are few health care investments that are so cost effective.”

# # #

Disclosures:  Scott Lovald, PhD, has nothing to disclose in relation to this study.

Study Abstract

About AAOS

Follow us on Facebook.com/AAOS1 and Twitter.com/AAOS1

For more information on bone and joint health, visit Orthoinfo.org

 
 
 
     
6300 North River Road, Rosemont, Illinois 60018-4262
Phone 847.823.7186 • Dept. Fax 847.823.7268 • Web
 
AAOS Home Page